HEART OF AUSTRALIA RESEARCH INSTITUTE: RESEARCH TRIAL
Zenith Trial: Hypertension
‘This trial is a Phase III double-blind, placebo-controlled study to evaluate the efficacy of a 6 monthly dose of the investigational product in addition to standard of care in reducing major adverse cardiovascular Events. Enrolling adult patients with hypertension, currently taking at least 2 anti-hypertensive medications’
